Overall Winner: Alan·83/ 100
A
AlanWinner
VS

Alan vs SigTuple

In-depth comparison — valuation, funding, investors, founders & more

Winner
A
Alan

🇫🇷 France · Jean-Charles Samuelian

Series DAI HealthcareEst. 2016

Valuation

$1.4B

Total Funding

$220M

83
Awaira Score83/100

500-1000 employees

Full Alan Profile →
S
SigTuple

🇮🇳 India · Rohit Kumar Pandey

Series BAI HealthcareEst. 2015

Valuation

N/A

Total Funding

$20M

60
Awaira Score60/100

100-500 employees

Full SigTuple Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Alan and SigTuple compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources. SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists.

Alan carries a known valuation of $1.4B, while SigTuple's valuation has not been publicly disclosed. On the funding side, Alan has raised $220M in total — $200M more than SigTuple's $20M.

SigTuple has 1 year more market experience, having been founded in 2015 compared to Alan's 2016 founding. In terms of growth stage, Alan is at Series D while SigTuple is at Series B — a meaningful difference for investors evaluating risk and upside.

Alan operates out of 🇫🇷 France while SigTuple is based in 🇮🇳 India, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Alan leads with a score of 83, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricAlanSigTuple
💰Valuation
$1.4B
N/A
📈Total Funding
$220MWINS
$20M
📅Founded
2016WINS
2015
🚀Stage
Series D
Series B
👥Employees
500-1000
100-500
🌍Country
France
India
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
83WINS
60

Key Differences

📈

Funding gap: Alan has raised $200M more ($220M vs $20M)

📅

Market experience: SigTuple has 1 year more (founded 2015 vs 2016)

🚀

Growth stage: Alan is at Series D vs SigTuple at Series B

👥

Team size: Alan has 500-1000 employees vs SigTuple's 100-500

🌍

Market base: 🇫🇷 Alan (France) vs 🇮🇳 SigTuple (India)

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Alan scores 83/100 vs SigTuple's 60/100

Which Should You Choose?

Use these signals to make the right call

A

Choose Alan if…

Top Pick
  • Higher Awaira Score — 83/100 vs 60/100
  • More established by valuation ($1.4B)
  • Stronger investor backing — raised $220M
  • France-based for regional compliance or proximity
  • Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources
S

Choose SigTuple if…

  • More market experience — founded in 2015
  • India-based for regional compliance or proximity
  • SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists

Users Also Compare

FAQ — Alan vs SigTuple

Is Alan bigger than SigTuple?
Alan has a disclosed valuation of $1.4B, while SigTuple's valuation is not publicly available, making a direct size comparison difficult. Alan employs 500-1000 people.
Which company raised more funding — Alan or SigTuple?
Alan has raised more in total funding at $220M, compared to SigTuple's $20M — a gap of $200M.
Which company has a higher Awaira Score?
Alan holds the higher Awaira Score at 83/100, compared to SigTuple's 60/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 23-point gap that reflects meaningful differences in scale or traction.
Who founded Alan vs SigTuple?
Alan was founded by Jean-Charles Samuelian in 2016. SigTuple was founded by Rohit Kumar Pandey in 2015. Visit each company's profile on Awaira for a full founder biography.
What does Alan do vs SigTuple?
Alan: Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources. The Paris company holds full insurance carrier status in France, Belgium, and Spain, operating as a licensed insurer rather than a distribution intermediary.\n\nThe company raised approximately $220 million including a Series D round from investors including Temasek, Coatue, and Index Ventures, reaching a valuation of approximately $1.4 billion. Alan reports over half a million members across its markets, covering employees at several thousand companies including Stripe, Spendesk, and Vinted, with strong growth in SME employer sales driven by its digital-first enrolment and claims experience. The Alan app provides members with health navigation, symptom checking, and AI-generated health content in addition to insurance card and claims management functionality.\n\nAlan competes in the European digital health insurance market against traditional mutuals including Malakoff Humanis and AG2R La Mondiale, as well as digital health insurers including Henner and Oscar Health in the US context. Its vertical integration as a licensed insurer combined with a technology platform differentiates it from insurtechs that distribute existing insurer products through digital channels, giving Alan full control over the member experience and claims economics. The company is considered one of the most significant French technology companies building in regulated financial services. SigTuple: SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists. The company's AI-Minth platform uses robotic sample preparation, high-resolution imaging, and deep learning analysis to deliver diagnostic-grade results.\n\nThe company raised approximately $20M in Series B funding and has deployed its automated microscopy systems at diagnostic labs, hospitals, and blood banks across India, processing millions of diagnostic samples. SigTuple has received regulatory approvals for its diagnostic AI products and has established partnerships with major diagnostic laboratory chains.\n\nIndia faces a severe shortage of qualified pathologists relative to population, creating an acute need for AI-assisted diagnostic automation. SigTuple's approach of combining hardware, robotics, and AI in an integrated system addresses the complete diagnostic workflow rather than just the software layer, creating higher deployment barriers but also higher switching costs and stronger network effects from accumulated diagnostic data.
Which company was founded first?
SigTuple was founded first in 2015, giving it 1 year of additional market experience. Alan was founded later in 2016. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Alan has approximately 500-1000 employees, while SigTuple has approximately 100-500. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Alan and SigTuple competitors?
Yes, Alan and SigTuple are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.